Long-term cardiovascular safety of COVID-19 vaccination according to brand, dose and combinations: Cohort study of 46 million adults in England (2024)

First Author: Ip S

Attributed to: Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2024.02.12.24302698

Publication URI: http://dx.doi.org/10.1101/2024.02.12.24302698

Type: Preprint